VTYX
NASDAQ · Pharmaceuticals
Ventyx Biosciences Inc
$14.00
+0.02 (+0.14%)
Open$13.99
Previous Close$13.98
Day High$14.00
Day Low$13.99
52W High$25.00
52W Low$2.26
Volume—
Avg Volume4.20M
Market Cap1.00B
P/E Ratio—
EPS$-1.50
SectorPharmaceuticals
Analyst Ratings
Hold
15 analysts
Price Target
+351.1% upside
Current
$14.00
$14.00
Target
$63.16
$63.16
$39.88
$63.16 avg
$74.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.43M | 24.73M | 29.85M |
| Net Income | 6.42M | 4.69M | 6.83M |
| Profit Margin | 23.4% | 19.0% | 22.9% |
| EBITDA | 7.71M | 7.29M | 9.18M |
| Free Cash Flow | 5.17M | 5.81M | 4.69M |
| Rev Growth | -7.8% | +2.8% | +7.3% |
| Debt/Equity | 0.43 | 0.48 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |